ArticleSarcoma2016

A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas.

Joanna Vitfell-Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.